Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPIVASERTIB vs CARBIDOPA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPIVASERTIB vs CARBIDOPA: Safety Overview

Metric CAPIVASERTIB CARBIDOPA
Total FAERS Reports 1,691 302
Deaths Reported 285 41
Death Rate 16.9% 13.6%
Hospitalizations 464 122
Average Patient Age 66.2 yrs 71.3 yrs
% Female Patients 94.6% 44.3%
FDA Approval Date Nov 16, 2023 Approved Prior to Jan 1, 1982
Manufacturer AstraZeneca Pharmaceuticals LP Dr. Reddy's Laboratories Inc
Route ORAL ORAL
Marketing Status Prescription Prescription